Skip to main content
OpenTrials

Clinical trial condition

Hepatitis B, Chronic

Explore clinical trials studying Hepatitis B, Chronic. Study availability and eligibility vary by location and protocol.

532 public trials 70 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis B, Chronic trial results

Completed

Study to Evaluate Efficacy and Safety of Switching From TDF to TAF in Adults With Chronic Hepatitis B Who Are Virologically Suppressed

NCT02979613

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • Los Angeles, California, United States
  • Palo Alto, California, United States
  • Pasadena, California, United States
  • San Diego, California, United States
View all 39 locations
View Trial Details
Completed

Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies

NCT00142298

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • Novartis Investigational Site Phoenix, Arizona, United States
  • Novartis Investigational Site Los Angeles, California, United States
  • Novartis Investigational Site Los Angeles, California, United States
  • Novartis Investigational Site Pasadena, California, United States
View all 39 locations
View Trial Details
Completed

Effectiveness of Nucleos(t)Ide Analogs (NUC) Therapy Among Naive CHB Patients in China

NCT01726439

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • Local Institution Beijing, Beijing Municipality, China
  • Local Institution Chongqing, Chongqing Municipality, China
  • Local Institution Chongqing, Chongqing Municipality, China
  • Local Institution Fuzhou, Fujian, China
View all 54 locations
View Trial Details
Completed

Study to Evaluate the Safety, Tolerability, and Efficacy of Vesatolimod in Combination With Tenofovir Disoproxil Fumarate (TDF) in Adults With Chronic Hepatitis B (CHB) Infection Who Are Currently Not Being Treated

NCT02579382

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • Los Angeles, California, United States
  • Palo Alto, California, United States
  • San Diego, California, United States
  • San Francisco, California, United States
View all 21 locations
View Trial Details
Completed

Peg-interferon ADDed to an Ongoing Nucleos(t)Ide Based Treatment in Patients With Chronic Hepatitis B to Induce Decrease of HBs-Antigen

NCT01524679

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • Facharztpraxis Prof. Löhr Wiesbaden, Hesse, Germany
  • Universitätsklinikum Aachen, Medizinische Klinik III Aachen, Germany
  • Leber- und Studienzentrum am Checkpoint Berlin, Germany
  • Charité Campus Virchow Klinikum, Universitätsmedizin Berlin Berlin, Germany
View all 24 locations
View Trial Details

Related conditions